Wendy F. DiCicco's most recent trade in EyePoint Pharmaceuticals Inc was a trade of 40,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Purchase of securities on an exchange or from another person at price $ 7.79 per share. | 20 Aug 2024 | 2,567 | 9,967 (0%) | 0% | 7.8 | 19,997 | Common Stock |
| Akari Therapeutics PLC (ADR) | Wendy F. DiCicco | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 158,473,915 | 158,473,915 (10%) | 10% | 0 | Ordinary Shares, par value $0.0001 per share | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,014 | 25,014 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 26,100 | 26,100 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 3,000 | 7,400 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2023 | 3,000 | 0 | - | - | Restricted Stock Units | |
| Swk Holdings Corp | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 17.64 per share. | 30 Dec 2022 | 1,120 | 5,403 (0%) | 0% | 17.6 | 19,757 | Common Stock |
| Swk Holdings Corp | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 17.64 per share. | 30 Dec 2022 | 779 | 6,182 (0%) | 0% | 17.6 | 13,742 | Common Stock |
| Swk Holdings Corp | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 17.00 per share. | 30 Sep 2022 | 1,162 | 3,474 (0%) | 0% | 17 | 19,754 | Common Stock |
| Swk Holdings Corp | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 17.00 per share. | 30 Sep 2022 | 809 | 4,283 (0%) | 0% | 17 | 13,753 | Common Stock |
| Swk Holdings Corp | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 17.47 per share. | 30 Jun 2022 | 1,137 | 2,312 (0%) | 0% | 17.5 | 19,863 | Common Stock |
| Swk Holdings Corp | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 16.88 per share. | 31 Mar 2022 | 1,175 | 1,175 (0%) | 0% | 16.9 | 19,834 | Common Stock |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 3,000 | 3,000 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 2,500 | 4,400 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2022 | 2,500 | 0 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) | |
| EyePoint Pharma Inc | Wendy F. DiCicco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 2,500 | 2,500 | - | - | Restricted Stock Units |